Esr1 Y537 mutations are associated with increased baseline circulating tumor cells enumeration for patients with estrogen receptor positive metastatic breast cancer

被引：0
|
作者：
Zhang, Qiang
Jiao, Jianhua
D'Amico, Paolo
Davis, Andrew A.
Qin, Weijun
Gerratana, Lorenzo
Jacob, Saya L.
Zhang, Youbin
Donahue, Jeannine
Qiang, Wenan
Shah, Ami N.
Flaum, Lisa
Gradishar, William
Platanias, Leonidas C.
Cristofanilli, Massimo
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-P2-01-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-01-08
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Circulating tumor DNA analysis for ESR1 mutations in patients with hormone receptor-positive metastatic breast cancer
    Sim, Sung Hoon
    Jeon, Su Yeon
    An, Kyoung Hee
    Kong, Sun Young
    Kwon, Min Jung
    Lee, Keun Seok
    Park, In Hae
    CANCER RESEARCH, 2018, 78 (13)
  • [2] Clinical Implications of Monitoring ESR1 Mutations by Circulating Tumor DNA in Estrogen Receptor Positive Metastatic Breast Cancer: A Pilot Study
    Li, Xuelu
    Lu, Jiawei
    Zhang, Lanxin
    Luo, Yaoting
    Zhao, Zuowei
    Li, Man
    TRANSLATIONAL ONCOLOGY, 2020, 13 (02): : 321 - 328
  • [3] Detection of activating estrogen receptor 1 (ESR1) mutation on single circulating tumor cells from metastatic breast cancer patients
    Paolilio, C.
    Mu, Z.
    Austin, L.
    Nguyen, T.
    Capoluongo, E.
    Fortina, P.
    Cristofanilli, M.
    CANCER RESEARCH, 2016, 76
  • [4] Noninvasive Detection of Activating Estrogen Receptor 1 (ESR1) Mutations in Estrogen Receptor-Positive Metastatic Breast Cancer
    Guttery, David S.
    Page, Karen
    Hills, Allison
    Woodley, Laura
    Marchese, Stephanie D.
    Rghebi, Basma
    Hastings, Robert K.
    Luo, Jinli
    Pringle, J. Howard
    Stebbing, Justin
    Coombes, R. Charles
    Ali, Simak
    Shaw, Jacqueline A.
    CLINICAL CHEMISTRY, 2015, 61 (07) : 974 - 982
  • [5] ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients
    Chu, David
    Paoletti, Costanza
    Gersch, Christina
    VanDenBerg, Dustin A.
    Zabransky, Daniel J.
    Cochran, Rory L.
    Wong, Hong Yuen
    Toro, Patricia Valda
    Cidado, Justin
    Croessmann, Sarah
    Erlanger, Bracha
    Cravero, Karen
    Kyker-Snowman, Kelly
    Button, Berry
    Parsons, Heather A.
    Dalton, W. Brian
    Gillani, Riaz
    Medford, Arielle
    Aung, Kimberly
    Tokudome, Nahomi
    Chinnaiyan, Arul M.
    Schott, Anne
    Robinson, Dan
    Jacks, Karen S.
    Lauring, Josh
    Hurley, Paula J.
    Hayes, Daniel F.
    Rae, James M.
    Park, Ben Ho
    CLINICAL CANCER RESEARCH, 2016, 22 (04) : 993 - 999
  • [6] ESR1 mutations in circulating tumor DNA (ctDNA) are associated with CTCs and increased hormone receptors in metastatic tumor tissues of patients with metastatic breast cancer (MBC).
    Zhang, Qiang
    Qin, Weijun
    D'Amico, Paolo
    Jiao, Jianhua
    Davis, Andrew A.
    Gerratana, Lorenzo
    Donahue, Jeannine
    Reduzzi, Carolina
    Manai, Marwa
    Jacob, Saya
    Zhang, Youbin
    Flaum, Lisa E.
    Behdad, Amir
    Cristofanilli, Massimo
    Platanias, Leonidas C.
    Shah, Ami N.
    Gradishar, William John
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Clinical relevance of ESR1 circulating mutations detection in hormone receptor positive metastatic breast cancer
    Clatot, Florian
    Perdrix, Anne
    Sefrioui, David
    Sarafan-Vasseur, Nasrin
    Di Fiore, Frederic
    BULLETIN DU CANCER, 2018, 105 (01) : 46 - 54
  • [8] Incidence and clinical relevance of ESR1 mutations in estrogen receptor positive breast cancer patients
    Takeshita, Takashi
    Tomiguchi, Mai
    Sueta, Aiko
    Nishimura, Sumiko
    Fujiki, Yoshitaka
    Goto, Risa
    Ibusuki, Mutsuko
    Yamamoto, Yutaka
    Iwase, Hirotaka
    ANNALS OF ONCOLOGY, 2017, 28 : 51 - 51
  • [9] Analysis of ESR1 Mutations in Single Circulating Tumor Cells from Metastatic Luminal Breast Cancer Patients Upon Estrogen Deprivation Therapy
    Franken, Andre
    Honisch, Ellen
    Reinhardt, Florian
    Meier-Stiegen, Franziska
    Yang, Liwen
    Alberter, Barbara
    Polzer, Bernhard
    Niederacher, Dieter
    Fehm, Tanja
    Neubauer, Harts
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 21 - 22
  • [10] Detection of activating estrogen receptor 1 (ESR1) in circulating tumor DNA (ctDNA) in hormone-receptor positive metastatic breast cancer (MBC)
    Austin, L.
    Rodriguez, A.
    Jaslow, R.
    Fortina, P.
    Nagy, R.
    Zill, O.
    Talasaz, A.
    Cristofanilli, M.
    CANCER RESEARCH, 2016, 76
12345